Application Notes & Case Studies

  1. Faster Trial Planning and Site Selection 4/15/2025

    Address the challenges of identifying the most suitable trial sites and investigators while optimizing feasibility planning, reducing screen failure rates, and improving patient retention.

  2. Ergomed's Solutions To The Challenges of Oncology Trials 4/15/2025

    Explore a pivotal Phase III global clinical trial investigating neoadjuvant immunotherapy for locally advanced squamous cell carcinoma of the head and neck (LA SCCHN).

  3. Strategic Pre-IND Consulting For Gene Therapy In Rare Leukemia 4/11/2025

    Learn about the collaborative efforts of an innovative biotech startup and Ergomed Consulting to overcome challenges in the pre-IND phase for a novel gene therapy targeting a rare form of leukemia.

  4. Early-Stage Development In Rare Pediatric Oncology 4/11/2025

    Learn about the strategic approach a biotechnology company utilized to address significant hurdles in launching a Phase 1 clinical trial for a novel therapy targeting a rare pediatric cancer.

  5. Market Approval For A Novel Non-Hodgkin Lymphoma (NHL) Therapy 4/11/2025

    Explore a collaboration that underscores the importance of strategic planning and regulatory engagement in the approval process.

  6. Post-Market Safety And Risk Management in DMD 4/11/2025

    The pharmaceutical company specializing in rare neurological diseases sought solutions after encountering significant hurdles in post-market safety surveillance.

  7. Setting A New Client Standard In Study Closeout Timelines 4/4/2025

    Learn how a top-10 global pharmaceutical company achieved a significantly faster time to market for a high-profile therapy.

  8. 6 Key Ways Real-World Data Is Advancing Colorectal Cancer Therapies 4/3/2025

    Real-world data (RWD) is transforming Colorectal cancer (CRC) research by complementing traditional clinical trials, accelerating drug development, and improving patient outcomes.

  9. Timely Lab Data To Inform Outreach To Healthcare Professionals 4/3/2025

    Learn how you can leverage a system that offers flexible data delivery formats and seamless integration into commercialization workflows while also ensuring HIPAA-compliant deidentified data for patient privacy.

  10. Driving Early-Phase Success In Advanced Solid Tumors Study 3/24/2025

    ​A European biotech company collaborated with TFS HealthScience to conduct an early-phase clinical trial focusing on advanced and metastatic solid tumors.